ARCHIVES

ODAC Recommends Femara Campath For FDA Approval.

This article is from The Cancer Letter archive.

Vol. 27 No. 01 | January 5, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Plans Conference On DES Late Effects, Reproductive Cancers

November 29, 1991

U of Pittsburgh Wins NCI Grant To Include End-of-Life Issues In Med. School Curriculum.

July 6, 2001

ASCO, AACI Ask $1.3 Billion for NCI, Full Funding Of Center Core, Group Grants

May 4, 1984

Bristol-Myers Claims Settlements Are Close In Lawsuits Over Generic Taxol, BuSpar

January 10, 2003

ACS Offers New Grants to Physicians

September 7, 1984

NCI Cooperative Group Clinical Trials Approved

October 30, 2009